Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02794883
Brief Title: Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

First Submitted : May 27, 2016
First Submitted that Met QC Criteria : June 6, 2016
First Posted : June 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 3, 2019
Last Update Posted : April 5, 2019